![Pearls in a shell](/media/hbmpartners/styles/hero_small/public/images/hero-images/hero-portfolio-companies.jpg?h=14832055&itok=DIQpNLis)
Monte Rosa Therapeutics
Industry
Oncology
Website
HBM contact
Company status
Public
Monte Rosa Therapeutics is a biotechnology company developing molecular glues to degrade disease-causing proteins. The company has developed a platform to rationally design small molecules that reprogram ubiquitin ligases to eliminate disease drivers previously deemed undruggable.
![Logo Monte Rosa Therapeutics](/media/hbmpartners/images/portfolio/logo/monte-rosa.png)